Fingerprint
Dive into the research topics of 'RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a real-world lenalidomide monotherapy cohort in relapsed or refractory diffuse large B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically